InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by DICICCO WENDY F, Director. Director active across 3 companies, notably Renovacor, Inc.. Cumulatively, 5 reports have been published. The latest transaction was disclosed on 31 March 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
€17,9131,175 shares@ €15.2452100.0% of flow
Common Stock
SEC:0000947871-22-000437:0·
02,500 shares0
Common Stock
SEC:0001562180-22-001418:0·
02,500 shares0
Common Stock
SEC:0001562180-22-001418·
018,800 shares0
Common Stock
SEC:0000899243-22-003303:0·
018,800 shares0
Common Stock
SEC:0000899243-22-003303·
5 of 5 declarations
About DICICCO WENDY F
Wendy F. DiCicco is the Interim Chief Financial Officer and a Board Member at Renovacor, Inc., EyePoint Pharmaceuticals, Inc., and SWK Holdings Corp. She oversees the financial operations of these companies, ensuring compliance and accuracy in financial reporting. Wendy plays a crucial role in managing financial resources while contributing to the strategic direction of each organization.
